For the year ending 2025-12-31, NMRA has $191,047K in assets. $87,176K in debts. $182,530K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 182,530 | |||
| Prepaid expenses and other current assets | 8,007 | |||
| Total current assets | 190,537 | |||
| Property and equipment, net | 40 | |||
| Operating lease right-of-use assets | 417 | |||
| Other assets | 53 | |||
| Total assets | 191,047 | |||
| Accounts payable | 3,379 | |||
| Accrued liabilities | 28,788 | |||
| Operating lease liabilities, current portion | 284 | |||
| Total current liabilities | 32,451 | |||
| Long term debt, net | 54,532 | |||
| Operating lease liabilities, noncurrent | 193 | |||
| Total liabilities | 87,176 | |||
| Common stock, 0.0001 par value 700,000 shares authorized as of december 31, 2025 and december 31, 2024 174,260 and 161,710 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 17 | |||
| Additional paid-in capital | 1,288,003 | |||
| Accumulated deficit | -1,184,149 | |||
| Total stockholders' equity | 103,871 | |||
| Total liabilities and stockholders' equity | 191,047 | |||
Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. (NMRA)